2nd Patient Assistance Programs

As unemployment continues to remain a core issue in the United States, the number of individuals losing health benefits is continuing to rise at an alarming rate. In addition to the 46 million Americans lacking health insurance, a growing number of people are either underinsured or are struggling to afford the costs of their medications in addition to life’s other necessities. Decreased coverage of prescription drugs coupled with the escalating price of medications has resulted in a situation where many patients skip doses, delay refills, or simply go without taking medicines that are essential to their health.

A substantial number of pharmaceutical and biotech companies help patients in need by providing free or discounted medications to those who meet specified eligibility requirements. Often through partnerships with nonprofit organizations, manufacturersupported patient assistance programs (PAPs), can be costly and difficult to run. Embedded in a complex regulatory environment, companies must take great care to ensure that their PAPs are compliant while also effective.

ExL Pharma’s 2nd Annual Patient Assistance Programs conference will cover regulatory, operational and strategic topics that are most relevant to pharmaceutical and biotech companies in this era of health care reform. Attendees will gain best practices and successful strategies for compliantly maximizing awareness of their PAPs, ensuring costeffective and successful operation of their programs, and obeying pertinent laws and regulations. In addition, this event will provide updates and practical techniques for manufacturers to prepare their PAPs for the impact associated with potential changes in the American health care system and the structure of marketplace.

Lindsay Slater
Conference Director
2nd Patient Assistance Programs

Kristen Hunter
Team Leader, Production
ExL Pharma